Wenbin Lin

Scientific Founder (Professor at University of Chicago)

Therapeutic Areas

Drug	Indication	Phase
NCP-based Combination Therapy	Solid Tumors	Pre-clinical
NCP + Checkpoint Inhibitor	Lowly immunogenic solid tumors	Pre-clinical